Clinical Scorecard: Revolutionizing Pain Management: The Impact of Collaboration, Innovation, and Entrepreneurial Approaches
At a Glance
Category
Detail
Condition
Chronic pain with complex physiological and social determinants
Key Mechanisms
Multimodal and multidisciplinary strategies integrating medications, restorative therapies, invasive interventions, and psychosocial care
Target Population
Adults experiencing chronic pain, including those inadequately managed by opioids or non-opioid medications
Care Setting
Interdisciplinary pain management programs, outpatient clinics, innovation labs, and digital health platforms
Key Highlights
Multimodal and multidisciplinary pain management programs improve pain, mood, daily activities, and quality of life.
Innovative entrepreneurial initiatives support development and commercialization of novel pain management technologies and therapies.
Advanced diagnostics, minimally invasive procedures, neuromodulation devices, external stimulation, and digital platforms expand treatment options.
Guideline-Based Recommendations
Diagnosis
Utilize advanced diagnostic technologies such as PET, MRI, and EEG to enhance understanding of pain processes.
Management
Implement multimodal and multidisciplinary strategies combining medications, restorative therapies, invasive interventions, and psychosocial care.
Incorporate integrative therapies like acupuncture to address emotional, mental, and cultural dimensions of pain.
Use advanced pharmaceutical innovations (e.g., ultrasound-triggered local anesthesia) and minimally invasive procedures for targeted pain relief.
Employ neuromodulation devices with patient-specific titration and consider external stimulation devices (TMS, TENS, PENS) as safe adjuncts.
Leverage digital health platforms, telemedicine, and virtual reality technologies to address psychological and social aspects of pain.
Monitoring & Follow-up
Monitor patient response to implanted devices due to risks of insufficient pain relief and surgical revision.
Assess effectiveness and patient tolerance of neuromodulation and external stimulation therapies regularly.
Risks
Recognize risks associated with opioid use including dependence and sedation.
Be aware of device-related complications such as surgical revision and device removal in implanted neuromodulation therapies.
Patient & Prescribing Data
Patients with chronic pain inadequately managed by conventional therapies including opioids and non-opioid medications
Opioids achieve on average 30% pain intensity reduction but pose significant risks; multimodal approaches and innovative therapies offer improved outcomes and reduced reliance on opioids.
Clinical Best Practices
Adopt interdisciplinary collaboration across pain-related specialties for holistic pain management.
Integrate conventional medicine with holistic and integrative therapies to address both physical and non-physical contributors to pain.
Support innovation and entrepreneurship to accelerate development and commercialization of novel pain management solutions.
Customize device and drug parameters to individual patient needs to optimize effectiveness and minimize complications.
Incorporate digital and virtual reality technologies to enhance behavioral therapy and pain perception modulation.
by Salman Hirani, Peter Vu, Mali Halac, Siri Bohacek, Barlas Benkli, David Jevotovsky, Julio Vega, Aliza Hirani, Vwaire Orhurhu, Charles Odonkor, Jesse Ehrenfeld, Iskander Shadid, Amanda Azadian, Brian Mayrsohn, Albert Kwon, Zishan Hirani, Uzondu Osuagwu, Justin Bird, Christopher Gilligan, Beth D Darnall, Kayode Williams, W Michael Hooten, Shriya Srinivasan
Patients with preoperative vitamin D deficiency had higher postoperative pain scores and opioid use after mastectomy, including more than triple the odds of moderate to severe pain within 24 hours of surgery.
